HADLIMA is a tumor necrosis factor (TNF) blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HADLIMA if you have any kind …

Learn more about HADLIMA™ (adalimumab-bwwd), an FDA-approved biosimilar of HUMIRA (adalimumab), and find resources for your patients and office.

HADLIMA is a tumor necrosis factor (TNF) blocker indicated for Rheumatoid Arthritis (RA) (1 1): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of...

Oct 17, 2025 · HADLIMA (adalimumab-bwwd) is supplied as a preservative-free, sterile, clear to opalescent, and colorless to pale brown solution for subcutaneous administration.

Jul 16, 2024 · If a patient or caregiver is to administer HADLIMA, instruct them in injection techniques and assess their ability to inject subcutaneously to ensure the proper …

HADLIMA is a tumor necrosis factor (TNF) blocker indicated for Rheumatoid Arthritis (RA) (1.1): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of …

Oct 13, 2025 · What is Hadlima Prefilled Syringe? Hadlima Prefilled Syringe is used alone or in combination with certain medicines. Hadlima Prefilled Syringe is used to treat juvenile …

Review dosing and administration options for HADLIMA™ (adalimumab-bwwd) and watch a video with step-by-step injection instructions.

Learn about how HADLIMA™ (adalimumab-bwwd) is administered and about the different dosage forms available for HADLIMA.

Hadlima is a tumor necrosis factor (TNF) blocker used to reduce signs and symptoms of various forms of arthritis and Crohn's disease.